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A marked increase in the prevalence of S. enterica 
serovar 4,[5],12:i:- with resistance to ampicillin, strep-
tomycin, sulphonamides and tetracyclines (R-type 
ASSuT) has been noted in food-borne infections and 
in pigs/pig meat in several European countries in 
the last ten years. One hundred and sixteen strains 
of S. enterica serovar 4,[5],12:i:- from humans, pigs 
and pig meat isolated in England and Wales, France, 
Germany, Italy, Poland, Spain and the Netherlands 
were further subtyped by phage typing, pulsed-field 
gel electrophoresis and multilocus variable number 
tandem repeat analysis to investigate the genetic rela-
tionship among strains. PCR was performed to iden-
tify the fljB flagellar gene and the genes encoding 
resistance to ampicillin, streptomycin, sulphonamides 
and tetracyclines. Class 1 and 2 integrase genes were 
also sought. Results indicate that genetically related 
serovar 4,[5],12:i:- strains of definitive phage types 
DT193 and DT120 with ampicillin, streptomycin, sul-
phonamide and tetracycline resistance encoded by 
blaTEM, strA-strB, sul2 and tet(B) have emerged in sev-
eral European countries, with pigs the likely reservoir 
of infection. Control measures are urgently needed to 
reduce spread of infection to humans via the food chain 
and thereby prevent the possible pandemic spread of 
serovar 4,[5],12:i:- of R-type ASSuT as occurred with 
S. Typhimurium DT104 during the 1990s.
Introduction
Infections with Salmonella enterica account for the 
second largest burden of bacterial gastrointestinal 
disease in the European Union (EU) [1]. The majority 
of Salmonella infections result in mild, self-limited ill-
ness and may not require treatment with antimicro-
bials. Nevertheless treatment with an appropriate 
antimicrobial can be life-saving in immunocompro-
mised patients and in invasive disease, such as 
Salmonella bacteraemia and meningitis. 
 
Serotyping according to the Kauffmann-White scheme 
is a widely used method for the initial characterisation 
of Salmonella isolates and is based on the antigenic 
variability of the somatic (O) and flagellar (H) antigens 
present in the cell wall of the organism [2]. Despite 
identification of more than 2,500 different serovars, 
the majority of cases of human infection are caused by 
a limited number of serovars. Most serovars are bipha-
sic and express two distinct flagellar antigens encoded 
by fliC (phase-1 flagellin) and fljB (phase-2 flagellin). 
However, some serovars fail to express either the 
phase-1 or phase-2 flagellar antigen, therefore are 
classed as monophasic. 
S. enterica serovar 4,[5],12:i:- is considered a monopha-
sic variant of serovar Typhimurium (4,[5],12:i:1,2) due 
to antigenic and genotypic similarities between the 
two serovars [3,4]. Serovar Typhimurium is the second 
most common serovar associated with human cases of 
Salmonella infection in the EU [1]. In contrast isolates 
of serovar 4,[5],12:i:- were rarely identified before the 
mid-1990s but are now among the top 10 most com-
mon serovars isolated from humans in several coun-
tries [3-8]. According to Enter-net data this serovar was 
the fourth most common serovar in confirmed cases 
of human salmonellosis in the EU in 2006 [1]. Cases of 
infection with serovar 4,[5],12:i:- have reportedly been 
severe, with a 70% hospitalisation rate during an out-
break in New York City in 1998 [9], although a much 
lower rate of 21% was observed during an outbreak 
in Luxembourg in 2006 [6]. Infections have also been 
particularly associated with cases of septicaemia in 
Thailand and Brazil [7,10]. Overall, cases of infection 
have been linked to a number of sources, including 
2 www.eurosurveillance.org
poultry and cattle, but particularly pigs and pork prod-
ucts [4,6,10-13]. Serovar 4,[5],12:i:- was among the top 
10 most common serovars isolated from both pigs and 
pig meat in the EU in 2006 [1]. 
A marked increase in prevalence of S. enterica serovar 
4,[5],12:i:- with resistance to ampicillin, streptomy-
cin, sulphonamides and tetracyclines (R-type ASSuT) 
has been noted both in food-borne infections and in 
pigs/pig meat in several European countries over the 
last ten years [6,8,14,15]. In the baseline study from 
fattening pigs (Commission Decision 2006/668/EC), 
Spanish strains of S. enterica serovar 4,[5],12:i:- repre-
sented 14.3% of the isolates, 52.5% of which were of 
R-type ASSuT (VISAVET Salmonella database, unpub-
lished data). In England and Wales cases of serovar 
4,[5],12:i:- infection have risen from 47 in 2005 to 
151 in 2009 (a 321% increase) against a backdrop of 
an overall decrease in the number of salmonellosis 
cases, with R-type ASSuT accounting for approximately 
30% of these strains (Health Protection Agency (HPA) 
Salmonella database, unpublished data). In France iso-
lations of serovar 4,[5],12:i:- increased from 99 to 410 
between 2005 and 2008 to become the third most com-
mon serovar isolated from humans, with 62% of strains 
in 2007 being of R-type ASSuT [16]. In Italy cases of 
serovar 4,[5],12:i:- infection have risen from 59 in 
2003 to 641 in 2009, with 75% of monophasic strains 
isolated in 2009 belonging to R-type ASSuT (with or 
without additional resistances) (Istituto Superiore di 
Sanità Salmonella database, unpublished data). A 
recent study described emergence of a clonal group 
of serovar Typhimurium and 4,[5],12:i:- R-type ASSuT 
strains in Italy, Denmark and the United Kingdom (UK) 
[17]. Resistance genes blaTEM-1, strA-strB, sul2 and tet(B) 
encoding resistance to ampicillin, streptomycin, sul-
phonamides and tetracyclines were localised on the 
bacterial chromosome. On the basis of resistance gene 
content and the lack of class 1 integrons these obser-
vations have suggested the existence of a new resist-
ance island that differs from the Salmonella Genomic 
Island-1 [17]. 
In response to the rapid increase in the frequency of 
S. enterica serovar 4,[5],12:i:-, R-type ASSuT strains, 
isolates from England and Wales, Germany, France, 
Italy, Poland, Spain and the Netherlands were com-
pared using phage typing, resistance gene charac-
terisation, pulsed-field gel electrophoresis (PFGE) 
and multilocus variable number tandem repeat (MLVA) 
analysis to evaluate the possibility of clonal spread of 
this emerging multidrug-resistant (MDR) strain.
Methods and Materials 
Isolate collection
The eight participating laboratories (the HPA Centre 
for Infections, London and the Veterinary Laboratories 
Agency, Weybridge in the UK, the Agence Française 
de Sécurité Sanitaire des Aliments in Maisons-Alfort, 
France, the Federal Institute for Risk Assessment in 
Berlin, Germany, the Istituto Superiore di Sanità in 
Rome, Italy, the National Institute of Public Health 
in Warsaw, Poland, the Health Surveillance Centre 
(VISAVET), University Complutense in Madrid, Spain 
and the Central Veterinary Institute of Wageningen 
in Lelystad, the Netherlands) were asked to sub-
mit a maximum of 10 isolates of S. enterica serovar 
4,[5],12:i:- exhibiting resistance (according to local 
protocols) to ampicillin, streptomycin, sulphonamides 
and tetracyclines, and isolated from humans, pigs or 
pig meat between 2006-2008. In addition, laboratories 
were invited to send a maximum of 10 isolates of sero-
var 4,[5],12:i:- exhibiting other resistance phenotypes. 
All isolates were sent to the HPA.
Strain characterisation
The Salmonella serotype was confirmed on the basis 
of the Kauffmann-White scheme and phage typing 
performed in accordance with HPA protocols [2,18]. In 
addition, isolates were screened using a duplex PCR 
targeting regions specific to serovar Typhimurium and 
to definitive phage type (DT) 104 and related strains of 
phage type (PT) U302 [19]. PCRs targeting the variable 
regions of the fljB genes encoding the phase-2 flagel-
lar antigens H:1,2, H:1,5, H:1,6, H:l,7, H:e,n,x, H:e,n,z15 
and H:1,w, were performed as previously described 
[20]. 
Susceptibility to a panel of 18 antimicrobials was 
determined by a breakpoint method in Isosensitest 
agar (Oxoid, Basingstoke, UK). The final plate concen-
trations (µg/mL) used routinely by the HPA on the basis 
of long-term studies were: ampicillin (A; 8), chloram-
phenicol (C; 8), gentamicin (G; 4), kanamycin (K; 16), 
neomycin (Ne; 8), streptomycin (S; 16), sulphonamides 
(Su; 64), tetracycline (T; 8), trimethoprim (Tm; 2), fura-
zolidone (Fu; 8), nalidixic acid (Nx; 16), ciprofloxacin 
(low-level (Cpl) 0.125; high-level (Cp) 1.0), amikacin 
(Ak; 4), cephalexin (Cx; 16), cephradine (Cr; 16), cefuro-
xime (Cf; 16), ceftriaxone (Cn; 1) and cefotaxime (Ct; 1). 
Resistance genes blaTEM, strA-strB, sul2 and tet(B), and 
classes 1 and 2 integrase genes were sought by PCR 
using previous described primers [21,22]. 
Molecular subtyping
PFGE was performed after digestion of genomic DNA 
with XbaI according to a standardised protocol [23]. 
The patterns were analysed using the Bionumerics 
software package (version 5.10; Applied Maths, Sint-
Martens-Latem, Belgium) and resulting band profiles 
were submitted to the PulseNet Europe database for 
assigning profile names. Dendrograms were con-
structed using the Dice similarity coefficient and the 
unweighted pair group method with arithmetic aver-
ages (UPGMA) with optimisation and position toler-
ance set at 1.5%. Multilocus variable number tandem 
repeat (MLVA) analysis was performed according to 
a previously described protocol [24]. MLVA profiles 
were assigned based on the fragment size amplified 
from each locus, with ‘NA’ used to denote a locus not 
present [25].  
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Results 
Some 122 serovar 4,[5],12:i:- isolates were sent to the 
HPA Laboratory of Gastrointestinal Pathogens, of which 
116 were confirmed as serovar 4,[5],12:i:-. These com-
prised 41 from England and Wales (20 from pigs and 
21 from humans, including three from patients with 
a history of recent travel to Thailand, Greece and an 
undisclosed destination), 10 isolates from France (iso-
lated from pig meat), 19 from Germany (12 from pigs, 
six from pig meat and one from a human), 23 from Italy 
(from humans), five from Poland (from humans), eight 
from Spain (from pigs) and 10 from the Netherlands 
(seven from human cases of infection; three from pigs). 
The H:1,2 phase-2 flagellar antigen could be serologi-
cally detected in the remaining six isolates. 
Phage typing using the Typhimurium typing phages 
identified 16 different PTs (Table 1). The most com-
monly identified PTs were DT193 (51 isolates), DT120 
(27 isolates) and RDNC (reacts but does not conform; 
11 isolates). DT193 was the most common PT identified 
Table 1
Phage type distribution among serovar 4,[5],12:i:- isolates from seven European countries, 2006-2008 (n=116) 
Country Phage type (number of isolates)
England and Wales 21 var (1), 120 (13a), 191 (1), 193 (21b), 208 (1), RDNC (2), U302 (2)
France 68 var (1), 120 (2), 193 (5), U311 (1), UT (1)
Germany 193 (13), 208 (1), 104b (2), RDNC (3)
Italy 7 var (3), 18 var (2), 120 (6), 193 (3), RDNC (5), U311 (3), UT (1)
Poland 120 (4), 104 (1)
Spain 18 (1), 193 (4), RDNC (1), U302 (1), U311 (1)
The Netherlands 12 (2), 120 (2), 193 (6)
RDNC: isolates that react with the typing phages, but do not conform to a recognised pattern; UT: isolates that do not react with any of the 
typing phages; var: variant.
Phage type as determined by the scheme of Anderson et al. [18].
a Including two strains associated with foreign travel.
b Includes one strain associated with foreign travel.
Table 2
Comparison of phage type and R-type with PFGE profile of serovar 4,[5],12:i:- isolates from seven European countries, 
2006-2008 (n=116)
PFGE profiles (STYMXB.)
ASSuT ASSuT and other resistancesb Other resistance patterns (not ASSuT)c
PT 0131 0083 0079 0010 0022 Othera 0131 0083 0079 0010 0022 Other 0131 0083 0079 0010 0022 Other
193 24 1 1 2 7 2 1 3 4 1 1 4
120 1 4 1 6 1 1 4 1 1 2 3 1 1
RDNC 1 2 1 2 1 1 2
U311 1 1 3
U302 1 1 1
7 var 1 2
12 2
208 2
18 var 1 1
UT 1 1
104B low 2
104 low 1
18 1
191 1
21 var 1
68 var 1
Total 26 5 6 8 4 14 2 4 2 1 1 11 4 5 4 1 1 17
PFGE: pulsed-field gel electrophoresis.
a Includes two untypable strains.
b Includes resistance patterns ACGNeKSSuTTmNxCpl (1 strain), ACKSSuT (1), ACSSuSpTTm (2), AGKNeSSuTTm (n=1), AGSSpSuT (n=1), 
AGSSuTTm (n=1), AKSSuT (n=1), ASSpSuTNxCpl (n=1), ASSuTNxCpl (n=2), ASSuTNxCpl (n=1) and ASSuTTm (n=9).
c Includes fully sensitive strains (n=6), AGST (n=1), AGSuT (n=1), AGT (n=1), ASSu (n=1), ASuT (n=1), SSuTm (n=1), SSuTTm (n=6), SuT (n=1), 
SuTTm (n=1) and T (n=9).
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in England and Wales, France, Germany, Spain and 
the Netherlands, while DT120 predominated in Italy 
and Poland. All 116 isolates were PCR-positive for the 
Typhimurium-specific fragment of the malic acid dehy-
drogenase gene but only four isolates (one belonging 
to DT104, two to PT U302 and one untypable) gave a 
product with primers targeting the 16S to 23S spacer 
region specific to DT104 and the related PT U302 [19]. 
Overall, 94 of 116 isolates were PCR-negative for all 
variants of the fljB gene coding for the phase-2 flagel-
lar antigen, including 48 of 51 DT193 and 17 of 27 DT120 
isolates. H:1,2-specific amplicons were detected in the 
remaining 22 isolates. 
Eighty-four isolates (72%) expressed resistance to 
ampicillin, streptomycin, sulphonamides and tetra-
cyclines (R-type ASSuT), with or without additional 
Figure
Comparison of the five most common PFGE profiles 
identified in serovar 4,[5],12:i:- isolates from seven 
European countries, 2006-2008
PFGE: pulsed-field gel electrophoresis.
Table 3
Comparison of common PFGE profiles with phage type, country of origin and sources of isolates, 2006-2008 (n=74)
STYMXB. Number of isolates Phage type (number of isolates) Country of origin (number of isolates.) Source (number of isolates)
0131 32
DT193 (30)
DT120 (1)
RDNC (1)
France (2)
The Netherlands (6)
England and Wales (16)
Germany (8)
Humans (10)
Pigs/pig meat (22)
0083 14
DT120 (10)
DT104 (2)
18 var (1)
DT193 (1)
France (2)
England and Wales (9)
Germany (2)
Italy (1)
Humans (5)
Pigs/pig meat (9)
0079 12
DT120 (5)
RDNC (2)
18 var (1)
7 var (1)
U302 (1)
U311 (1)
England and Wales (2)
Spain (1)
Italy (9)
Humans (11)
Pigs/pig meat (1)
0010 10
DT120 (7)
RDNC (2)
DT193 (1)
France (1)
The Netherlands (1)
England and Wales (1)
Poland (3)
Spain (1)
Italy (1)
Germany (2)
Humans (5)
Pigs/pig meat (5)
0022 6
DT193 (4)
DT120 (1)
U311 (1)
France (2)
England and Wales (1)
Poland (1)
Spain (1)
Germany (1)
Humans (2)
Pigs/pig meat (4)
PFGE: pulsed-field gel electrophoresis.
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resistance(s) (Table 2). Six isolates were fully sensi-
tive to all antimicrobials in the test panel. Eighty-three 
of 92 ampicillin-resistant iolates carried blaTEM, 85 of 
96 streptomycin-resistant isolates carried strA-strB, 
Table 4
Subdivision of the five most common PFGE profiles using MLVA analysis, 2006-2008 (n=74)
PFGE pattern Number of strains
MLVA profile (based on number of tandem repeats at each locus)a
SSTR9 STTR5 STTR6 STTR10
STTR3
27 bp 33 bp
STYMXB.0131
10
8
5
3
3
1
1
1
3 11
13
12
13
9
10
10
12
14
8
NA 2 11
STYMXB.0083
5
4
1
1
1
1
1
3
13
12
11
11
13
14
13
9
6
11
12
10
NA
NA 2 11
STYMXB.0079
2
2
1
1
1
1
1
2
1
3
11
13
12
13
11
12
12
13
13
15
13
11
10
8
12
9
12
9
NA
NA
NA 2 11
STYMXB.0010
3
2
1
1
1
1
1
3 14
12
12
12
13
14
15
9
10
7
9
7
10
10
NA 2 11
STYMXB.0022
2
1
1
1
1
3 12
13
14
15
9
13
11
9
10
NA 3
2
2
11
NA: locus not present; PFGE: pulsed-field gel electrophoresis; MLVA: multilocus variable number tandem repeat analysis.
a Number of tandem repeats only listed where it differs from the most common repeat number in each PFGE profile.
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88 of 99 sulphonamide-resistant isolates carried sul2 
and 93 of 105 tetracycline-resistant isolates carried 
tet(B) (data not shown). Of 84 R-type ASSuT strains, 
68 possessed blaTEM, strA-strB, sul2 and tet(B) resist-
ance genes. Eighty-two percent of RDNC isolates, 
80% of DT193 and 74% of DT120 were of R-type ASSuT 
(with/without additional resistance(s)), with resistance 
encoded by genes blaTEM, strA-strB, sul2 and tet(B) in 
78%, 75% and 56% of isolates respectively. Isolates of 
R-type ASSuT were negative for both class 1 and 2 inte-
grase genes; these were found only in strains express-
ing resistance to aminoglycosides and/or trimethoprim. 
Among the remaining 16 R-type ASSuT strains from the 
present study that did not carry blaTEM, strA-strB, sul2 
and tet(B), 11 strains lacked only one of tet(B), blaTEM-1 
or sul2, one strain each lacked blaTEM-1 and tet(B) or 
strA-strB and tet(B), one strain lacked blaTEM-1, strA-strB 
and sul2 and one strain lacked all four genes. These 
strains belonged to phage types DT120 (five strains), 
DT193 (four strains), RDNC (two strains), and one each 
belonged to phage types DT104, DT18 variant, U302, 
U311 and UT. 
PFGE analysis identified 36 unique banding pro-
files among 114 strains; two strains were untypable. 
These were grouped into 12 clusters of two or more 
strains and 23 patterns corresponding to a single 
isolate (data not shown). Sixty-five percent (74/114) 
of strains were represented by one of five band-
ing patterns (STYMXB.0131, n=32, STYMXB.0083, 
n=14, STYMXB.0079, n=12, STYMXB.0010, n=10, and 
STYMXB.0022, n=6) that shared more than 90% simi-
larity (Figure, Table 3). Strains from humans and pigs 
or pig meat were represented in each common PFGE 
pattern. The majority of strains with PFGE patterns 
STYMXB.0131 and STYMXB.0022 were phage type 
DT193, while patterns STYMXB.0083, STYMXB.0079 
and STYMXB.0010 were dominated by phage type 
DT120 (Table 3). Some country-specific differences 
were noted within the distribution of PFGE patterns: 
nine of the 12 STYMXB.0079 strains were from Italy, 
three of the five Polish strains were STYMXB.0010 
and six of 10 strains from the Netherlands were pat-
tern STYMXB.0131 (Table 3). STYMXB.0010 was the 
only profile identified in all seven countries. However, 
larger numbers of strains need to be analysed to deter-
mine whether these country-specific distributions hold 
true. Patterns STYMXB.0131 and STYMXB.0010 were 
dominated by R-type ASSuT strains (representing 81% 
and 80% of strains, respectively), whereas resistance 
profiles of the other common PFGE profiles were more 
variable (Table 2). 
MLVA typing identified 45 different profiles that dif-
fered by loss or addition of tandem repeats at loci 
STTR9, STTR5, STTR6 and STTR3, and was able to fur-
ther subdivide the five most common PFGE profiles 
(Table 4). Ninety-one percent (105/116) of strains failed 
to amplify a fragment from the Typhimurium-specific 
virulence plasmid pSLT-bound locus STTR10. The five 
most common MLVA profiles (3-11-9-NA-211, n=12; 
3-12-9-NA-211, n=13; 3-13-10-NA-211, n=12; 3-14-9-NA-
211, n=7; and 3-13-9-NA-211, n=6) accounted for 43% 
of strains and differed by only one to three tandem 
repeats at locus STTR5 and one repeat at locus STTR6. 
The most frequently occurring combination of pheno-
typic and genotypic characteristics was that 51 of 116 
(44%) serovar 4,[5],12:i:- isolates belonged to phage 
type DT193. Of these 51, 48 were PCR-negative for 
fljB. Among the 51 DT193 isolates, 37 were of R-type 
ASSuT (plus additional resistance to chloramphenicol, 
aminoglycosides and/or trimethoprim in four isolates) 
encoded by blaTEM, strA-strB, sul2 and tet(B), and 36 
exhibited PFGE profile STYMXB.0131, which could be 
further divided into eight related MLVA profiles. Isolates 
bearing these characteristics were isolated in England 
and Wales (including one isolate from a patient with 
history of recent travel to Thailand), France, Germany 
and the Netherlands.
Discussion
Antimicrobial resistance is a serious public health 
problem limiting the therapeutic options available to 
clinicians treating complicated Salmonella infections. 
In recent years there has been an overall decline in the 
level of resistance in serovar Typhimurium in several 
European countries as a result of a reduction in the 
number of isolates of penta-resistant DT104 [14]. To 
some extent this reduction has been counteracted by 
an increase in prevalence of serovar 4,[5],12:i:- isolates 
expressing resistance to ampicillin, streptomycin, sul-
phonamides and tetracyclines [8,17]. 
One of the first reports of serovar 4,[5],12:i:- in Europe 
was of an isolate grown in the late 1980s from a 
chicken carcass in Portugal [26]. This serovar emerged 
in Spain in strains from humans and pork or pork prod-
ucts during 1997, and subsequently became the fourth 
most common Salmonella serovar identified from 1998 
to 2000 [11]. All isolates belonged to phage type U302. 
These isolates were classed as monophasic variants 
of serovar Typhimurium due to presence of an IS2000 
fragment located in a Typhimurium-specific location 
within the fliB-fliA intergenic region and amplification 
of a Typhimurium DT104- and U302-specific region [3]. 
All 116 monophasic isolates in this study harboured 
the Typhimurium-specific fragment of the malic acid 
dehydrogenase gene, suggesting that these strains 
are monophasic variants of serovar Typhimurium. 
However, the majority (97%) were negative for the 
DT104- and U302-specific region, suggesting that these 
monophasic isolates may not be related to the serovar 
4,[5],12:i:- strain(s) that emerged in Spain. This was 
confirmed by phage typing, which identified DT193 as 
the most common PT, followed by DT120, thereby add-
ing to the diversity of phage types of serovar 4,[5],12:i:- 
linked to serovar Typhimurium. DT193 and DT120 have 
consistently fallen within the top five phage types of 
serovar Typhimurium from cases of human infection 
in England and Wales in recent years (HPA Salmonella 
database, unpublished data). It is plausible that at 
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least some of this increase may be attributed to the 
emergence of serovar 4,[5],12:i:- DT193 and DT120 
strains. Putative Typhimurium isolates sent from pri-
mary diagnostic laboratories to the HPA Salmonella 
Reference Unit are only phage-typed and not routinely 
subjected to further serological examination. This may 
result in misclassification as serovar Typhimurium and 
under-reporting of this serovar in England and Wales, 
and in other countries where phage typing is used in 
lieu of full serotyping to identify strains as serovar 
Typhimurium. Serovar 4,[5],12:i:- DT193 strains have 
previously been isolated from human cases of infec-
tion and/or pigs in Luxembourg and Spain [6,13], while 
monophasic DT120 strains were identified in Italy [8]. 
The Spanish PT U302 serovar 4,[5],12:i:- strains were 
PCR-negative for H:1,2 [11], as were the majority (81%) 
of monophasic isolates in this study. Previous pub-
lished work has shown that the lack of phase-2 flagellar 
expression may be due to different mutations (includ-
ing point mutations) and partial or complete deletions 
in fljB and adjacent genes [4,27]. Monophasic strains 
in which the phase-2 flagellar antigen is not detected 
serologically but can be detected by PCR may contain 
deletions in a part of fljB that leave the H:1,2-specific 
PCR primer binding sites intact, or they may represent 
‘serotype inconsistent’ strains [27]. These are serovar 
Typhimurium strains in which serological detection 
of the phase-2 flagellar antigen may be inconsist-
ent. This may be due to problems with flagellar phase 
reversal, which is a time-consuming and technically 
demanding procedure that may result in misclassifi-
cation of Typhimurium strains as serovar 4,[5],12:i:-. 
Alternatively, the invertible promoter controlling 
expression of fljB and fliC may have become locked in 
one position allowing only expression of fliC in these 
strains [4]. The range of mechanisms that can result in 
non-expression of the phase-2 flagellar antigen make 
definitive identification of serovar 4,[5],12:i:- prob-
lematic. It is possible that molecular serotyping could 
be used as a basis to define such strains as serovar 
4,[5],12:i:- or Typhimurium, but as yet such methods 
lack standardisation, are not in place in most coun-
tries and may not be suitable for laboratories other 
than reference facilities. Given that there may be dis-
crepancy in detection of the phase-2 flagellar antigen 
between classical and molecular serotyping, an inter-
national agreement both on the definition of monopha-
sic strains and on detection methodology is required. 
Without reaching such a consensus the true incidence 
of such Typhimurium-like strains is difficult to assess; 
only the harmonisation and the sharing of methods will 
allow accurate comparison of reported data.
In contrast to the monophasic variants isolated in 
Thailand and Spain, which commonly expressed addi-
tional resistance to gentamicin and trimethoprim-sul-
phamethoxazole and/or chloramphenicol [10,11] and to 
serovar 4,[5],12:i:- strains isolated in Brazil and New 
York City, which were infrequently MDR [7,9], the coun-
tries participating in this study observed an increase 
in isolates of serovar 4,[5],12:i:- with resistance to 
ampicillin, streptomycin, sulphonamides and tetracy-
clines only. Characterisation of the resistance genes 
responsible for this phenotype identified blaTEM, strA-
strB, sul2 and tet(B) in 81% of isolates. Such genes 
have also been identified in isolates of Typhimurium 
DT193 R-type ASSuT obtained during 2005 in England 
and Wales from raw beef and a human case of infec-
tion, although the majority of strains tested harboured 
tet(A) rather than tet(B) (unpublished data). Analysis of 
a 10 kb chromosomal region of a Typhimurium DT193 
revealed the presence of an strB-strA-sul2-repC-repA 
region derived from plasmid RSF1010 located upstream 
of blaTEM-1 and downstream of a class 1 integron [28]. 
The resistance genes encoding the tetra-resistant 
phenotype in isolates of serovars Typhimurium and 
4,[5],12:i:- from Italy, Denmark and the UK were also 
identified as blaTEM-1, strA-strB, sul2 and tet(B), but 
all isolates were negative for class 1 integrons [17]. 
Transfer experiments were unsuccessful and probes 
specific for these genes bound to a 750 kb I-CeuI digest 
fragment, suggesting a chromosomal location and 
existence of a new resistance island. As in the present 
study, strains with other R-types than ASSuT, but with 
related PFGE profiles and harbouring one or more of 
blaTEM-1, strA-strB, sul2 and tet(B) were identified. This 
suggests that rearrangements or deletions may occur 
within the resistance island leading to partial resist-
ance patterns [17]. In contrast, resistance to ampicil-
lin, streptomycin, sulphonamides and tetracyclines 
was mediated by plasmid-borne blaTEM-1 and tet(A), and 
a class 1 integron harbouring aadA2 and sul1 in the 
Spanish serovar 4,[5],12:i:- U302 isolates [29]. 
Thirty-six profiles were identified among the 114 
strains typable by PFGE, thereby supporting previous 
observations that serovar 4,[5],12:i:- can demonstrate 
considerable diversity, even among strains from a sin-
gle country [4,9,13,27]. However, serovar 4,[5],12:i:- 
strains have been reported to be less heterogenic 
than serovar Typhimurium strains [9,27,30]. Serovar 
Typhimurium demonstrates considerable diversity as 
evidenced by phage typing and molecular typing, but 
with certain clonal strains such as multidrug-resistant 
DT104 [31]. The most common PFGE profile identified in 
our study was STYMXB.0131, which, together with four 
other closely related banding patterns (STYMXB.0022, 
STYMXB.0079, STYMXB.0010 and STYMXB.0083), 
accounted for 65% of isolates. Previously submitted 
STYMXB.0131 patterns in the PulseNet Europe data-
base belonged to serovar Typhimurium DT193 and 
PT507 (according to the Dutch phage typing scheme) 
strains isolated from human cases of infection in 
Finland, the Netherlands and England and Wales. 
Patterns STYMXB.0131 and STYMXB.0022 have also 
been identified in Typhimurium DT193 strains from 
humans, cattle and raw beef in England and Wales 
(unpublished data), while patterns STYMXB.0083 and 
STYMXB.0010 have been identified in Typhimurium 
DT120 isolates in England and Wales and in Denmark 
[32]. These observations are consistent with previous 
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studies that serovar 4,[5],12:i:- strains are genotypi-
cally closely related to serovar Typhimurium [4,7,8,27]. 
Patterns STYMXB.0079 and STYMXB.0010 represented 
58% of serovar Typhimurium R-type ASSuT strains in 
Italy [8]. Pattern STYMXB.0131 has also been iden-
tified among Danish serovar 4,[5],12:i:- strains [17]. 
Serovar 4,[5],12:i:- R-type ASSuT strains belonging to 
profile STYMXB.0131 were responsible for two major 
outbreaks in Luxembourg in 2006 where pork meat 
was suspected as the vehicle for the outbreaks [6]. In 
Italy, profiles STYMXB.0079 and STYMXB.0010 repre-
sented 83% of serovar 4,[5],12:i:- R-type ASSuT strains 
[8]. However, the majority of strains were phage type 
U302 or untypable; only 8% of the isolates belonged to 
DT120 and none were DT193.
MLVA typing was also applied to the strain panel as 
the technique is reportedly more discriminatory than 
PFGE and provides unambiguous typing data that is 
free of the bias generated by differences in resistance 
genotype that reportedly affects PFGE [33]. Using the 
nomenclature of Larsson et al. allowed easy recogni-
tion of related profiles [25]. The five most common 
MLVA profiles identified in this study, and single locus 
variants thereof, have previously been identified in 
S. Typhimurium DT193 R-type ASSuT strains iso-
lated from humans, pigs, cattle and beef products in 
England and Wales in 2005-2006 (unpublished data) 
and in isolates of Typhimurium DT120 R-type ASSuT 
associated with a putative outbreak in humans in the 
northeast of England in 2006 [32]. That all monophasic 
strains were typable by MLVA, using the Lindstedt et al. 
Typhimurium-specific scheme [24], and shared closely 
related profiles with these Typhimurium isolates pro-
vides tentative further evidence that monophasic 
4,[5],12:i:- isolates derive from serovar Typhimurium. 
The data presented here suggest that a serovar 
4,[5],12:i:- DT193 R-type ASSuT clone with PFGE profile 
STYMXB.0131 has emerged from serovar Typhimurium 
and spread within several European countries, with 
pigs as a likely reservoir of infection. Isolates of sero-
var 4,[5],12:i:- DT120 R-type ASSuT with closely related 
PFGE profiles were identified in humans and pigs from 
five of the participating countries. The diversity of 
PFGE and MLVA profiles within serovar 4,[5],12:i:- DT193 
and DT120 R-type ASSuT isolates, and the differences 
between these isolates and those previously described 
in Spain [30], suggests that serovar 4,[5],12:i:- is 
likely to represent several clones or strains that have 
emerged independently from serovar Typhimurium. 
Recent genotypic studies have shown that in addition 
to the Spanish 4,[5],12:i- clone, other 4,[5],12:i:- line-
ages exist [27]. 
In the first ten months of 2009, DT193 and DT120 
accounted for 18% and 11% of Typhimurium isolates 
in England and Wales, respectively. In contrast, DT104 
accounted for only 7% of Typhimurium isolates (HPA 
Salmonella database, unpublished data). Serovar 
4,[5],12:i:- has already caused substantial outbreaks 
in several countries, with reports of severe infections 
and also deaths [6,7,9,10].  In order to prevent a global 
epidemic of these newly emerging clones or strains, as 
occurred with Typhimurium DT104, appropriate inter-
vention strategies need to be put in place as soon as 
possible, particularly in pig husbandry throughout the 
EU.
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